Charles Simone, MD, FASTRO

Charles B. Simone, II, MD, FASTRO, FACRO is Research Professor and Chief Medical Officer of New York Proton Center and Full Member in Radiation Oncology at Memorial Sloan Kettering Cancer Center. He is an internationally recognized expert in proton therapy, reirradiation, SBRT, and innovative thoracic oncology clinical trial strategies. Dr. Simone was previously Chief of Thoracic Oncology at University of Pennsylvania, Director of the Penn Mesothelioma and Pleural Program, and Director of Clinical Research and Operations in Radiation Oncology at Penn. He was then Medical Director of Maryland Proton Treatment Center, Chair of the Clinical Research Committee for Maryland's Comprehensive Cancer Center, proton Fellowship Director, and Director of the Stereotactic Radiation Therapy Program. He completed his undergraduate and medical training at UPenn and radiation oncology residency at NCI/NIH, where he was chief resident. Dr. Simone is an NIH, NSF, and DOD-funded investigator, published >670 scientific articles/chapters, and given >640 lectures to national/international audiences. He is the national Principal Investigator or Co-Chair of 8 NIH-funded cooperative group trials (NRG Oncology=5, SWOG=1, ECOG-ACRIN=1, PCG=1) and three-time ARRO Educator of the Year winner. He is the Proton Collaborative Group Board President. He Chairs: PCG Lung Committee, ASTRO Annual Meeting Scientific Committee Lung/Thoracic Track, ASTRO Lung Resource Panel Committee, ASTRO Blue Ribbon Lung Panel, NRG Oncology Particle Therapy Work Group, American Radium Society AUC Thoracic Committee, PTCOG Thoracic Subcommittees, NCI/Radiosurgery Society SFRT and FLASH Working Group, Varian FlashForward Consortium Scientific Committee, and Varian ProtonConnect User Group. He is Editor-in-Chief of Annals of Palliative Medicine.

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none